Detalhe da pesquisa
1.
The evaluation of the anti-cancer drug elesclomol that forms a redox-active copper chelate as a potential anti-tubercular drug.
IUBMB Life
; 71(5): 532-538, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30698324
2.
Topical Delivery of Artemisone, Clofazimine and Decoquinate Encapsulated in Vesicles and Their In vitro Efficacy Against Mycobacterium tuberculosis.
AAPS PharmSciTech
; 20(1): 33, 2019 Jan 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30604176
3.
Reversed isoniazids: Design, synthesis and evaluation against Mycobacterium tuberculosis.
Bioorg Med Chem
; 26(4): 833-844, 2018 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29373270
4.
Design, synthesis, and In vitro antituberculosis activity of 2(5H)-Furanone derivatives.
IUBMB Life
; 68(8): 612-20, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27346745
5.
A novel inhibitor of gyrase B is a potent drug candidate for treatment of tuberculosis and nontuberculosis mycobacterial infections.
Antimicrob Agents Chemother
; 59(3): 1455-65, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25534737
6.
Sulfamethoxazole enhances the antimycobacterial activity of rifampicin.
J Antimicrob Chemother
; 67(12): 2908-11, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22875849